Amphastar Pharmaceuticals
(NASDAQ) AMPH
Amphastar Pharmaceuticals Financials at a Glance
Market Cap
$927.82M
Revenue (TTM)
$719.89M
Net Income (TTM)
$98.09M
EPS (TTM)
$2.03
P/E Ratio
10.06
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$20.45
Volume
9,344
Open
$19.91
Price
$20.45
Volume
9,344
Open
$19.91
Previous Close
$20.45
Daily Range
$19.88 - $20.59
52-Week Range
$17.03 - $31.26
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$20.45
Volume
9,344
Open
$19.91
Previous Close
$20.45
Daily Range
$19.88 - $20.59
52-Week Range
$17.03 - $31.26
AMPH News
AMPH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Amphastar Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
1,976
CEO
Yong Feng Zhang, PhD
Website
www.amphastar.comHeadquarters
Rancho Cucamonga, CA 91730, US
AMPH Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
20%
Net Income Margin
14%
Return on Equity
13%
Return on Capital
10%
Return on Assets
6%
Earnings Yield
9.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$927.82M
Shares Outstanding
45.37M
Volume
9.34K
Short Interest
0.00%
Avg. Volume
484.04K
Financials (TTM)
Gross Profit
$356.06M
Operating Income
$140.40M
EBITDA
$149.10M
Operating Cash Flow
$156.12M
Capital Expenditure
$34.88M
Free Cash Flow
$121.23M
Cash & ST Invst.
$282.81M
Total Debt
$656.00M
Amphastar Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$183.10M
-1.8%
Gross Profit
$85.67M
-1.1%
Gross Margin
46.79%
N/A
Market Cap
$927.82M
N/A
Market Cap/Employee
$457.51K
N/A
Employees
2,028
N/A
Net Income
$24.43M
-35.7%
EBITDA
$38.54M
-40.7%
Quarterly Fundamentals
Net Cash
$373.19M
+13.0%
Accounts Receivable
$143.56M
+4.0%
Inventory
$176.89M
+15.1%
Long Term Debt
$646.43M
+0.5%
Short Term Debt
$9.57M
+36.0%
Return on Assets
6.02%
N/A
Return on Invested Capital
9.54%
N/A
Free Cash Flow
$24.59M
+48.0%
Operating Cash Flow
$32.86M
+13.2%